Pictet Asset Management Holding Sa Madrigal Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 207,043 shares of MDGL stock, worth $58.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
207,043
Previous 208,484
0.69%
Holding current value
$58.9 Million
Previous $64.3 Million
6.6%
% of portfolio
0.08%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$627 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$597 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$575 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$567 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$562 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.86B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...